Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer. [electronic resource]
Producer: 20210308Description: 413-422 p. digitalISSN:- 1097-0215
- Adult
- Aged
- Class I Phosphatidylinositol 3-Kinases -- genetics
- Drug Administration Schedule
- Endometrial Neoplasms -- drug therapy
- Female
- Heterocyclic Compounds, 3-Ring -- administration & dosage
- Humans
- Middle Aged
- Mutation
- Neoplasm Recurrence, Local -- drug therapy
- Precision Medicine
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.